Gulf Keystone Petroleum Ltd (GKP)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 212.50 |
|---|---|
| 52-week range | 160.60 – 235.00 |
| Return, 1 month / 3 months | +7.3% / +20.5% |
| Return, 1 year / 3 years | +23.1% / +128.7% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 35.7% |
| Worst drawdown (1 year) | -28.3% |
| Average daily value traded | 120.12M GBX |
| Dividend yield | 3.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Gulf Keystone Petroleum is an oil and gas company focused on the Kurdistan Region of Iraq, where it operates the Shaikan field. It produces crude oil and sells it into local and export markets, moving output by pipeline and by road. The company is based in London and its ordinary stock trades on the London Exchange. Its business centres on operating and developing its Kurdish oil assets and managing the associated facilities and infrastructure.
Gulf Keystone Petroleum Ltd trades under the code GKP on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Gulf Keystone Petroleum Ltd (GKP) trades on the London Exchange in UK. It last closed at GBX 212.50 on 23 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 621 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 23.1% and over the last three months it rose 20.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.9% | ||
| From 52-week high | -8.4% | ||
| Momentum | 76 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 20.5% | ||
| 6-month return | 12.8% | ||
| 12-month return, skipping the last month | 14.7% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.3% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 120.12M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.3% |
|---|---|
| 1 month | +7.3% |
| 3 months | +20.5% |
| 6 months | +12.8% |
| 1 year | +23.1% |
| 3 years | +128.7% |
| 5 years | +115.7% |
Signals
| 50-day / 200-day average | 194.80 / 184.97 |
|---|---|
| Golden / death cross (60 days) | Golden, 21 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 11.62 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | GBP 0.0344 |
| 9 Apr 2026 | GBP 0.0425 |
| 11 Sep 2025 | GBP 0.0844 |
| 3 Apr 2025 | GBP 0.0899 |
| 17 Oct 2024 | GBP 0.0711 |
| 4 Jul 2024 | GBP 0.0533 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.